Insider Transactions in Q1 2025 at Coherus Bio Sciences, Inc. (CHRS)

Date	Insider	Transaction	Ownership Type	Shares Traded	Value / Price
Jan 20 2025	Paul Reider Chief Commercial Officer	SELL Payment of exercise price or tax liability	Direct	4,858 -5.59%	$4,858 $1.39 P/Share
Jan 20 2025	Bryan J Mc Michael Chief Financial Officer	SELL Payment of exercise price or tax liability	Direct	1,711 -6.94%	$1,711 $1.39 P/Share
Jan 20 2025	Dennis M Lanfear President & CEO	SELL Payment of exercise price or tax liability	Direct	11,810 -1.69%	$11,810 $1.39 P/Share
Jan 07 2025	Bryan J Mc Michael Chief Financial Officer	SELL Payment of exercise price or tax liability	Direct	1,711 -6.49%	$1,711 $1.57 P/Share
Jan 04 2025	Paul Reider Chief Commercial Officer	SELL Payment of exercise price or tax liability	Direct	2,277 -2.55%	$2,277 $1.66 P/Share
Jan 04 2025	Dennis M Lanfear President & CEO	SELL Payment of exercise price or tax liability	Direct	11,810 -1.67%	$11,810 $1.66 P/Share

Receive a notification when an Institution or Guru buys or sells CHRS shares.

Notify only if

Value

Get notified when an Coherus Bio Sciences, Inc. insider buys or sells CHRS shares.

Notify only if

Operation

Value

Type

Receive news related to Coherus BioSciences, Inc.